Approaches toward peptide-based immunotherapy of autoimmune diseases.
Adorini
L
L
Sandoz Pharma Ltd., Basel, Switzerland.
Guéry
J C
JC
Trembleau
S
S
D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control; D000949:Histocompatibility Antigens Class II / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D010455:Peptides / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology
D000949:Histocompatibility Antigens Class II; D010455:Peptides